Activest Wealth Management’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Activest Wealth Management’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30	Hold	10	–	–	﹤0.01%	1309
2026 Q1	$31	Hold	10	–	–	﹤0.01%	1193
2025 Q4	$40	Hold	10	–	–	﹤0.01%	1089
2025 Q3	$124	Hold	10	–	–	﹤0.01%	1049
2025 Q2	$210	Hold	10	–	–	﹤0.01%	944
2025 Q1	$296	Hold	10	–	–	﹤0.01%	912
2024 Q4	$325	Hold	10	–	–	﹤0.01%	583
2024 Q3	$402	Hold	10	–	–	﹤0.01%	494
2024 Q2	$516	Buy	+10	New	+$473	﹤0.01%	459

Other funds holding CANF

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Activest Wealth Management's CANF Position: Q2 2026 in Review

Activest Wealth Management held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q2 2026 at 10 shares worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

Activest Wealth Management first reported a position in CANF in Q2 2024 and has held it in 9 quarters since. The position peaked at $516 in Q2 2024. 4 funds tracked by Wall St. Rank hold CANF as of Q2 2026.

Activest Wealth Management held 10 shares of Can-Fite BioPharma American Depositary Shares worth $30 as of Q2 2026.
Activest Wealth Management left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q2 2026.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1309 holding.
Activest Wealth Management first reported a position in Can-Fite BioPharma American Depositary Shares in Q2 2024 and has held it in 9 quarters since.
Activest Wealth Management's Can-Fite BioPharma American Depositary Shares position peaked at $516 in Q2 2024.
4 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.